Flag­ship-found­ed Evelo Bio­sciences will dis­solve af­ter find­ing no 'vi­able al­ter­na­tive'

Evelo Bio­sciences, a Flag­ship Pi­o­neer­ing biotech that set out to cre­ate new oral med­i­cines dubbed mon­o­clon­al mi­cro­bials, has de­cid­ed to dis­solve af­ter mul­ti­ple clin­i­cal fail­ures …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER